Cigna Group CI
NYSE · United States · Health Services
$271.83-3.43 (-1.25%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Cigna Group (CI) used its 2026 Investor Day to roll out a new Lead to One vision, outline a US$3b modernization push, and reaffirm both current guidance and long term growth targets. Cigna Group’s recent Investor Day comes after a period where momentum has cooled, with the share price at US$271.83 and a 90 day share price return down 5.5%, while the 5 year total shareholder return of 46.8% points to a much stronger longer run outcome. Compare Cigna Group’s new long term plan with peers by...
Cigna Group (NYSE:CI) reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day. President and CEO Brian Evanko said the company has reshaped its portfolio over the past deca
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Cigna Group has delivered a mixed run in recent years, and investors now have to decide whether the current US$275.26 share price lines up with what its earnings justify. The question is whether that price fairly reflects what the business is generating today, rather than just where the stock has traded before. Over the past 5 years the stock has gained about 50.0%, which puts real weight on whether the underlying earnings profile can support that kind of long term outcome. The business...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.